Correlation Between Carabao Group and DOD Biotech

Can any of the company-specific risk be diversified away by investing in both Carabao Group and DOD Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carabao Group and DOD Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Carabao Group Public and DOD Biotech Public, you can compare the effects of market volatilities on Carabao Group and DOD Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carabao Group with a short position of DOD Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carabao Group and DOD Biotech.

Diversification Opportunities for Carabao Group and DOD Biotech

0.19

Correlation Coefficient

Carabao Group  DOD Biotech

Average diversification

The 3 months correlation between Carabao and DOD is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Carabao Group Public and DOD Biotech Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOD Biotech Public and Carabao Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carabao Group Public are associated (or correlated) with DOD Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOD Biotech Public has no effect on the direction of Carabao Group i.e., Carabao Group and DOD Biotech go up and down completely randomly.

Pair Corralation between Carabao Group and DOD Biotech

Assuming the 90 days trading horizon Carabao Group is expected to generate 184.78 times less return on investment than DOD Biotech. But when comparing it to its historical volatility, Carabao Group Public is 36.2 times less risky than DOD Biotech. It trades about 0.01 of its potential returns per unit of risk. DOD Biotech Public is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  374.00  in DOD Biotech Public on October 9, 2024 and sell it today you would lose (215.00) from holding DOD Biotech Public or give up 57.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Carabao Group Public  vs.  DOD Biotech Public

Carabao Group Public

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Carabao Group Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Carabao Group is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

DOD Biotech Public

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DOD Biotech Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Carabao Group and DOD Biotech

The main advantage of trading using opposite Carabao Group and DOD Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carabao Group position performs unexpectedly, DOD Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOD Biotech will offset losses from the drop in DOD Biotech's long position.

The idea behind Carabao Group Public and DOD Biotech Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.